950509-60-1 Usage
Description
(R)-1-(2,2,2-trifluoro-ethyl)-3-(tritylamino)-1,3,4,5-tetrahydro-1-benzazepin-2-one is a complex chemical compound belonging to the tetrahydro-1-benzazepin-2-one class. It features a trifluoroethyl group and a tritylamino group, which may contribute to its potential pharmacological properties and applications.
Uses
Used in Pharmaceutical Industry:
(R)-1-(2,2,2-trifluoro-ethyl)-3-(tritylamino)-1,3,4,5-tetrahydro-1-benzazepin-2-one is used as a potential pharmaceutical compound for its unique molecular structure and functional groups. (R)-1-(2,2,2-trifluoro-ethyl)-3-(tritylamino)-1,3,4,5-tetrahydro-1-benzazepin-2-one may have applications in the development of new drugs, targeting various diseases and conditions due to its specific interactions at the molecular level.
Used in Chemical Research:
In the field of chemical research, (R)-1-(2,2,2-trifluoro-ethyl)-3-(tritylamino)-1,3,4,5-tetrahydro-1-benzazepin-2-one serves as a subject for further investigation. Its synthesis, reactivity, and potential applications in creating new materials or compounds are of interest to researchers, as understanding its properties can lead to advancements in related fields.
Check Digit Verification of cas no
The CAS Registry Mumber 950509-60-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,0,5,0 and 9 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 950509-60:
(8*9)+(7*5)+(6*0)+(5*5)+(4*0)+(3*9)+(2*6)+(1*0)=171
171 % 10 = 1
So 950509-60-1 is a valid CAS Registry Number.
950509-60-1Relevant articles and documents
Discovery of a novel class of benzazepinone Nav1.7 blockers: Potential treatments for neuropathic pain
Hoyt, Scott B.,London, Clare,Gorin, David,Wyvratt, Matthew J.,Fisher, Michael H.,Abbadie, Catherine,Felix, John P.,Garcia, Maria L.,Li, Xiaohua,Lyons, Kathryn A.,McGowan, Erin,MacIntyre, D. Euan,Martin, William J.,Priest, Birgit T.,Ritter, Amy,Smith, McHardy M.,Warren, Vivien A.,Williams, Brande S.,Kaczorowski, Gregory J.,Parsons, William H.
, p. 4630 - 4634 (2008/02/10)
A series of benzodiazepines and benzazepinones were synthesized and evaluated as potential sodium channel blockers in a functional, membrane potential-based assay. One member of the benzazepinone series, compound 47, displayed potent, state-dependent block of hNav1.7, and was orally efficacious in a rat model of neuropathic pain.
